Skip to content
Screener

Ocular Therapeutix OCUL Business Segments — Facilities Expense

Similar metrics at other companies

EyePoint, Inc. logo
EYPTFacilities Expense
$1.66M+69.3%
EyePoint, Inc. logo
EYPTFacilities Expense
$1.66M+69.3%
CarParts.com, Inc. logo
PRTSSingle Reportable — Rent And Facilities Expense
$3.04M-12.7%
Rigetti Computing, Inc. logo
RGTISingle Reportable — Rent And Facilities
$2.51M+67.6%
CWA
CWANReportable Segment — Facilities expense
$7.27M+91.4%
Theravance Biopharma logo
TBPHSingle Reportable — Research And Development Expense Facilities Depreciation And Other Allocated Expenses
$803K-9.4%

Other financials

Income statement

See full
Revenue$10.8M+0.8%
Gross profit$9.5M+0.2%
Operating income-$93.3M-46.0%
Net income-$88.6M-38.3%
EPS (diluted)-$0.40-5.3%

Balance sheet

See full
Cash & equivalents$666.7M+90.7%
Total debt$79.5M+4.2%
Total equity$581.6M+119%
Total assets$732.5M+80.5%

Cash flow

See full
Operating cash flow-$66.0M-47.7%
CapEx$4.7M+141%
Free cash flow-$70.7M-51.6%

Valuation

See full
Market cap$1.92B-11.7%
Enterprise value$1.33B-28.4%
P/S36.9×-1.5×

Profitability

See full
Gross margin87.2%-3.4pp
Operating margin-575.4%+1,233pp
Net margin-558.2%+1,493pp
FCF margin-463%+2,860pp

Returns & leverage

See full
Return on equity-68.6%+17.0pp
Debt / equity0.1×-0.2×
Current ratio14.8×+4.6×

Where this comes from

Reported directly by Ocular Therapeutix in its filing.

Tagged under the XBRL concept ocul:FacilitiesExpense.

The source filing: Ocular Therapeutix’s 10-Q, filed May 5, 2026.

Filed
May 5, 2026, 7:28 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-055256
Line itemThree Months Ended / March 31, 2026Three Months Ended / March 31, 2025
All other costs1,8093,255
Selling and marketing (a)14,07512,817
General and administrative (a)11,6069,661
Facilities (b)2,2701,664
Stock-based compensation15,58210,456
Depreciation1,260981
Interest income6,0503,826
Interest expense(2,777)(2,984)

Item 1. Financial Statements (unaudited)

FAQ

What is Ocular Therapeutix's business segments — facilities expense?
Ocular Therapeutix (OCUL) reported business segments — facilities expense of $2.27M in Q1 2026.
How has Ocular Therapeutix's business segments — facilities expense changed year-over-year?
Ocular Therapeutix's business segments — facilities expense increased by 36.4% year-over-year, from $1.66M to $2.27M.
What is the long-term trend for Ocular Therapeutix's business segments — facilities expense?
Over 3 years (2022 to 2025), Ocular Therapeutix's business segments — facilities expense has grown at a 10.5% compound annual growth rate (CAGR), from $5.3M to $7.16M.
What does business segments — facilities expense mean?
This metric captures the costs associated with maintaining physical office, laboratory, and manufacturing facilities, including rent, utilities, and property maintenance. It reflects the fixed real estate footprint required to support the company's ongoing operations.

Ask your AI about Ocular Therapeutix's business segments — facilities expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude